Long-term follow-up of different refractory systemic vasculitides treated with rituximab

Clinical Rheumatology

Volumn 30, Issue 9, 2011, Pages 1241-1245

  Rees, Frances ^a   Yazdani, Ramin ^a   Lanyon, Peter ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Refractory; Relapse; Rituximab; Vasculitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB; TACROLIMUS;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CRYOGLOBULINEMIA; CUTENOUS POLYARTERITIS NODOSA; FEMALE; FOLLOW UP; HUMAN; MALE; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REFRACTORY SYSTEMIC VASCULITIS; RELAPSE; RETREATMENT; RETROSPECTIVE STUDY; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULITIS; YOUNG ADULT;

EID: 80052641130     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1756-8     Document Type: Article

References (14)

1. KA Keogh SR Ytterberg FC Fervenza KA Carlson DR Schroeder U Specks 2006 Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial Am J Respir Crit Care Med 173 180 187 16224107 10.1164/rccm.200507-1144OC 1:CAS:528:DC%2BD28XmslSksLo%3D (Pubitemid 43187890)
2. K Keogh M Wylam J Stone U Specks 2005 Induction of remission by B lymphocyte depletion in eleven cases with refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 52 1 262 268 15641078 10.1002/art.20718 (Pubitemid 40129256)
3. J Stone P Merkel R Spiera P Seo C Langford, et al. 2010 Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 221 232 20647199 10.1056/NEJMoa0909905 1:CAS:528:DC%2BC3cXptVKru78%3D
4. R Jones J Cohen Tervaert T Hauser R Luqmani M Morgan C Peh, et al. 2010 The European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 211 220 20647198 10.1056/NEJMoa0909169 1:CAS:528:DC%2BC3cXptVKhs7c%3D
5. S Lovric U Erdbruegger P Kumpers, et al. 2009 Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 cases Nephrol Dial Transplant 24 179 185 18685144 10.1093/ndt/gfn430 1:CAS:528:DC%2BD1MXhtVKrsg%3D%3D
6. RB Jones AJ Ferraro Chaudhry, et al. 2009 A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 60 7 2156 2168 19565480 10.1002/art.24637 1:CAS:528:DC%2BD1MXptlKrsLo%3D
7. R Stasi E Stipa G Del Poeta S Amadori AC Newland D Provan 2006 Long term observation of cases with anti-neutophil cytoplasmic antibody-associated vasculitis treated with rituximab Rheumatology 45 11 1432 1436 16632482 10.1093/rheumatology/kel098 1:CAS:528:DC%2BD28XhtFeisb3O (Pubitemid 44605482)
8. PM Aries B Hellmich J Voswinkel M Both B Noelle K Holl-Ulrich, et al. 2006 Lack of efficacy of Rituximab in Wegener's granulomatosis with refractory granulomatous manifestations Ann Rheum Dis 65 853 858 16269425 10.1136/ard.2005.044420 1:CAS:528:DC%2BD28XntF2mu7c%3D
9. M Martinez Del Pero A Chaudhry R Jones P Sivasothy P Jani D Jayne 2009 B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study Clin Otolaryngol 34 328 335 19673980 10.1111/j.1749-4486.2009.01968.x 1:STN:280:DC%2BD1MrltFChtA%3D%3D
10. N Tamura R Matsudaira M Hirashima M Ikeda M Tajima N Nawata, et al. 2007 Two cases of refractory Wegener's granulomatosis successfully treated with rituximab Intern Med 46 7 409 414 17409608 10.2169/internalmedicine.46.6156 (Pubitemid 46585484)
11. P Eriksson 2005 Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab J Intern Med 257 6 540 548 15910558 10.1111/j.1365-2796.2005.01494.x 1:CAS:528: DC%2BD2MXlsl2mu70%3D (Pubitemid 40776514)
12. SR Taylor AD Salama L Joshi CD Pusey SL Lightman 2009 Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis Arthritis Rheum 60 5 1540 1547 19404964 10.1002/art.24454
13. JC Jennette RJ Falk K Andrassy, et al. 1994 Nomenclature of systemic vasculitides: the proposal of an international consensus conference Arthritis Rheum 37 187 192 8129773 10.1002/art.1780370206 1:STN:280:DyaK2c7nsF2mug%3D%3D (Pubitemid 24065492)
14. O Flossmann P Bacon K de Groot D Jayne N Rasmussen P Seo K Westman R Luqmani 2007 Development of comprehensive disease assessment in systemic vasculitis Ann Rheum Dis 66 3 283 292 16728460 (Pubitemid 46579626)